3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid is a lipid of Sterol Lipids (ST) class. 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid is associated with abnormalities such as Cholestasis and Little's Disease. The involved functions are known as inhibitors, Signal Transduction, Phosphorylation, Cell Survival and Detergents. 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid often locates in Protoplasm. The related lipids are Promega.
To understand associated biological information of 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid is suspected in Cholestasis, Little's Disease and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with 3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Crohn Disease | D003424 | 12 associated lipids |
| Cholelithiasis | D002769 | 16 associated lipids |
| Blastomycosis | D001759 | 5 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tang Y et al. | Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease. | 2016 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:27102560 |
| Zia Q et al. | Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index. | 2016 | Curr. Pharm. Des. | pmid:26648472 |
| Serafim C et al. | Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B. | 2016 | Int J Pharm | pmid:26617315 |
| Xie G et al. | Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. | 2016 | Int. J. Cancer | pmid:27273788 |
| Paredes K et al. | Virulence and Experimental Treatment of Trichoderma longibrachiatum, a Fungus Refractory to Treatment. | 2016 | Antimicrob. Agents Chemother. | pmid:27216056 |
| Coelho AC et al. | A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome. | 2016 | PLoS Negl Trop Dis | pmid:27144739 |
| Nalwanga D and Henning L | If It Looks Like a Duck, Swims Like a Duck, and Quacks Like a Duck--Does It Have to Be a Duck? | 2016 | PLoS Negl Trop Dis | pmid:27124154 |
| Shen C et al. | Deoxycholic acid (DCA) confers an intestinal phenotype on esophageal squamous epithelium via induction of the stemness-associated reprogramming factors OCT4 and SOX2. | 2016 | Cell Cycle | pmid:27096226 |
| Surampalli G et al. | Safety evaluation of naringenin upon experimental exposure on rat gastrointestinal epithelium for novel optimal drug delivery. | 2016 | Drug Deliv | pmid:24937377 |
| Fan J et al. | Shear rheology and in-vitro release kinetic study of apigenin from lyotropic liquid crystal. | 2016 | Int J Pharm | pmid:26657272 |